Aeterna Zentaris Inc. | CIK:0001113423 | 3

  • Filed: 3/28/2018
  • Entity registrant name: Aeterna Zentaris Inc. (CIK: 0001113423)
  • Generator: Workiva (WebFilings)
  • SEC filing page: http://www.sec.gov/Archives/edgar/data/1113423/000162828018003635/0001628280-18-003635-index.htm
  • XBRL Instance: http://www.sec.gov/Archives/edgar/data/1113423/000162828018003635/aezs-20171231.xml
  • XBRL Cloud Viewer: Click to open XBRL Cloud Viewer
  • EDGAR Dashboard: https://edgardashboard.xbrlcloud.com/edgar-dashboard/?cik=0001113423
  • Open this page in separate window: Click

    • ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory

    23 Segment information
    The Company operates in a single operating segment, being the biopharmaceutical segment.
    Geographical information
    Revenues by geographical area are detailed as follows:
     
     
    Years ended December 31,
     
     
    2017
     
    2016
     
    2015
     
     
    $
     
    $
     
    $
    United States
     
    452

     
    410

     
    217

    China
     
    262

     
    249

     
    302

    Singapore
     
    —

     
    101

     
    —

    British Virgin Islands
     
    206

     
    100

     
    —

    Switzerland
     
    —

     
    —

     
    312

    Other
     
    3

     
    51

     
    45

     
     
    923

     
    911

     
    876

    Amounts presented:
     
     
     
     
     
     
    Within discontinued operations
     
    —

     
    —

     
    331

    Within continuing operations
     
    923

     
    911

     
    545

     
     
    923

     
    911

     
    876


    Revenues have been allocated to geographic regions based on the country of residence of the Company's external customers or licensees.
    Non-current assets* by geographical area are detailed as follows:
     
     
    December 31,
     
     
    2017
     
    2016
     
     
    $
     
    $
    Germany
     
    8,792

     
    7,793

    United States
     
    2

     
    2

    Canada
     
    10

     
    32

     
     
    8,804

     
    7,827

    _______________________________    
    *
    Non-current assets include property, plant and equipment, identifiable intangible assets and goodwill.
    Major customers representing 10% or more of the Company's revenues in each of the last three years are as follows:
     
     
    Years ended December 31,
     
     
    2017
     
    2016
     
    2015
     
     
    $
     
    $
     
    $
    Company 1*
     
    —

     
    —

     
    312

    Company 2
     
    —

     
    20

     
    217

    Company 3
     
    262

     
    249

     
    302

    Company 4
     
    323

     
    222

     
    —

    Company 5
     
    129

     
    167

     
    —

    Company 6
     
    —

     
    101

     
    —

    Company 7
     
    206

     
    100

     
    —

    _______________________________
    *Related to Cetrotide® (discontinued operations).